Reshma Rangwala

EVP & Chief Medical Officer

EVP & Chief Medical Officer at Karyopharm Therapeutics Inc., filing insider transactions between 2026-03-02 and 2026-05-14.

Total Purchases

—

0 transactions

Total Sales

$56K

3 transactions

Companies Traded

3 total filings

Active Since

2026-03-02

Last: 2026-05-14

Companies

Karyopharm Therapeutics Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-05-14	KPTI	Sale	408	$9.50	$4K	56.8K	SEC ↗
2026-04-21	KPTI	Sale	449	$8.94	$4K	56.3K	SEC ↗
2026-03-02	KPTI	Sale	5,066	$9.41	$48K	56.7K